Form 4: Fulgent Genetics President and COO Jian Xie Sells Shares to Cover Tax Obligations

Jian Xie, President and COO of Fulgent Genetics, sold 653 shares of common stock on May 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 23, 2024, Jian Xie, the President and COO of Fulgent Genetics, sold 653 shares of common stock.
• The sale was executed at a price of $21.14 per share.
• The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 23, 2023.
• Following the transaction, Mr. Xie directly owns 356,022 shares of Fulgent Genetics common stock.
• Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust, dated January 27, 2010, for which he serves on the investment committee.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to equity compensation.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders, as it is a routine transaction.

Key Dates